Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A

Transfusion

Volumn 43, Issue 1, 2003, Pages 78-84

  Sarkodee Adoo, Clarence ^a,b   Sotirescu, Dan ^a   Sensenbrenner, Lyle ^a   Rapoport, Aaron P ^a   Cottler Fox, Michele ^a   Tricot, Guido ^a   Ruehle, Kathy ^a   Meisenberg, Barry ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b City of Hope Samaritan BMT Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN A; TACROLIMUS;

ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD DONOR; CAUSE OF DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; DRUG BLOOD LEVEL; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PLASMAPHERESIS; RISK ASSESSMENT; STATISTICAL ANALYSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

ADULT; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; PLASMAPHERESIS; RETROSPECTIVE STUDIES; TACROLIMUS; THROMBOSIS;

EID: 0037226991     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00282.x     Document Type: Article

References (38)

1. Zeigler ZR, Shadduck RK, Nemunaitis J, et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995;15:247-53.
2. Zarifian A, Meleg-Smith S, O'Donovan R, et al. Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney Int 1999;55:2457-66.
3. Iacopino P, Pucci G, Arcese W, et al. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO). Bone Marrow Transplant 1999;24: 47-51.
4. Furlong T, Storb R, Anasetti C, et al. Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities. Bone Marrow Transplant 2000;26:985-91.
5. Nash RA, Pineiro LA, Storb R, et al. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood 1996;88:3634-41.
6. Au WY, Lie AK, Lam CC, et al. Tacrolimus (FK 506) induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin. Haematologica 2000;85:659-62.
7. Burke GW, Ciancio G, Cirocco R, et al. Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement. Transplantation 1999;68:1336-42.
8. Holman MJ, Gonwa TA, Cooper B, et al. FK506-associated thrombotic thrombocytopenic purpura. Transplantation 1993;55:205-6.
9. Trimarchi HM, Truong LD, Brennan S, et al. FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. Transplantation 1999;67:539-44.
10. Rabinowe SN, Soiffer RJ, Tarbell NJ, et al. Hemolyticuremic syndrome following bone marrow transplantation in adults for hematologic malignancies. Blood 1991;77: 1837-44.
11. Carlson K, Smedmyr B, Hagberg H, et al. Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas. Bone Marrow Transplant 1993;11:205-8.
12. Chappell ME, Keeling DM, Prentice HG, Sweny P. Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation? Bone Marrow Transplant 1988;3:339-47.
13. Vantelon JM, Munck JN, Bourhis JH, et al. Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy. Bone Marrow Transplant 2001;27:531-6.
14. Matsuda Y, Hara J, Miyoshi H, et al. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous bone marrow transplantation in young children. Bone Marrow Transplant 1999;24:919-23.
15. Schriber JR, Herzig GP. Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 1997;34:126-33.
16. Moake JL, Byrnes JJ. Thrombotic microangiopathies associated with drugs and bone marrow transplantation. Hematol Oncol Clin North Am 1996;10:485-97.
17. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994;14:495-504.
18. Busca A, Uderzo CBMT. Bone marrow transplant associated thrombotic microangiopathy. Hematology 2000;5:53-67.
19. Fuge R, Bird JM, Fraser A, et al. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Haematol 2001;113:58-64.
20. Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989;73:2018-24.
21. Atkinson K, Biggs JC, Hayes J, et al. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes. Br J Haematol 1983;54:59-67.
22. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998;339:1585-94.
23. Furlan M, Robles R, Galbusera M, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998;339:1578-84.
24. van der Plas RM, Schiphorst ME, Huizinga EG, et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura. Blood 1999;93:3798-802.
25. Kuga T, Kohda K, Hirayama Y, et al. Pulmonary venoocclusive disease accompanied by microangiopathic hemolytic anemia 1 year after a second bone marrow transplantation for acute lymphoblastic leukemia. Int J Hematol 1996;64:143-50.
26. Sarkodee-Adoo C, Gojo I, Heyman MR. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome (letter). N Engl J Med 1999;340:1368; discussion 1369.
27. Burke GA, McGraw ME, MacIver AG. The role of early renal biopsy in cyclosporin induced thrombotic microangiopathy. Pediatr Nephrol 1999;13:564-6.
28. Paquette RL, Tran L, Landaw EM. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis. Bone Marrow Transplant 1998;22:351-7.
29. Roy V, Rizvi MA, Vesely SK, George JN. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 2001;27:641-6.
30. Iwata H, Kami M, Hori A, et al. An autopsy-based retrospective study of secondary thrombotic thrombocytopenic purpura. Haematologica 2001;86:669-70.
31. Hori A, Kami M, Hamaki T, et al. Thrombotic thrombocytopenic purpura without any evidence of thrombotic lesions at autopsy. Ann Hematol 2001;80:496-8.
32. Raife TJ, Lager DJ. Chronic thrombotic microangiopathy associated with antineoplastic therapy with minimal hematologic effects. Mayo Clin Proc 2002;77:323-8.
33. Croce K, Flaumenhaft R, Rivers M, et al. Inhibition of calpain blocks platelet secretion, aggregation, and spreading. J Biol Chem 1999;274:36321-7.
34. Zeigler Z, Kelton J, Moore J, et al. Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura. Bone Marrow Transplant 1999;24:641-5.
35. Chemnitz J, Fuchs M, Blau W, et al. Fatal thrombotic thrombocytopenic purpura as a rare complication following allogeneic stem cell transplantation. Ann Hematol 2000;79:527-9.
36. Teruya J, Styler M, Verde S, et al. Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation. J Clin Apheresis 2001;16:169-74.
37. Gharpure VS, Devine SM, Holland HK, et al. Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. Bone Marrow Transplant 1995;16:715-6.
38. Kolker O, Sviri S, Linton DM, et al. Plasmapheresis for thrombotic thrombocytopenic purpura following bone marrow transplantation. Acta Haematol 2001;105:156-8.